Tokyo, Dec. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060031) titled 'An exploratory randomized controlled trial comparing changes in blood protein expression levels following vegetable juice or mineral water consumption interventions' on Dec. 9.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -but assessor(s) are blinded Control - Placebo

Primary Sponsor: Institute - Tohoku University

Condition: Condition - CVD / lung cancer / dementia / chronic kidney disease / eye disease / prostate cancer Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - This study randomly assigned participants to either a vegetable juice intake group or a mineral water intake group, and conducted an exploratory comparison of changes in blood proteins after 12 weeks of intake. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - For 12 weeks, consume one bottle (approximately 200 ml) of commercially available vegetable juice every morning. Interventions/Control_2 - For 12 weeks, consume one bottle (approximately 200 ml) of commercially available mineral water every morning.

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Individuals who have previously undergone the Fones Visuas Test and meet the following criteria:

(1) Those for whom the Fones Visuas Test item "Risk of myocardial infarction or stroke within the past 4 years [Type I]" is greater than 2.2% (Risk Level 2 or higher) Key exclusion criteria - Exclude individuals who meet any of the following criteria: (1) Individuals for whom written or electronic consent to participate in the study cannot be obtained (2) Individuals with a history of allergies, such as feeling unwell after consuming vegetable juice, or individuals who dislike vegetable juice and cannot drink it consistently (3) Individuals who are currently pregnant and receiving care at an obstetrics and gynecology clinic (4) Individuals receiving regular medication (5) Individuals deemed unsuitable by the principal investigator Target Size - 60

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 10 Month 22 Day Date of IRB - 2025 Year 11 Month 10 Day Anticipated trial start date - 2026 Year 01 Month 30 Day Last follow-up date - 2026 Year 06 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068656

Disclaimer: Curated by HT Syndication.